New Millennium Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.03K | Buy |
44
+1
| +2% | +$46 | ﹤0.01% | 316 |
|
2025
Q1 | $2.65K | Sell |
43
-11
| -20% | -$677 | ﹤0.01% | 315 |
|
2024
Q4 | $3.05K | Buy |
54
+12
| +29% | +$678 | ﹤0.01% | 345 |
|
2024
Q3 | $2.2K | Hold |
42
| – | – | ﹤0.01% | 296 |
|
2024
Q2 | $1.74K | Buy |
+42
| New | +$1.74K | ﹤0.01% | 309 |
|
2024
Q1 | – | Sell |
-41
| Closed | -$2.1K | – | 108 |
|
2023
Q4 | $2.1K | Sell |
41
-97
| -70% | -$4.96K | ﹤0.01% | 319 |
|
2023
Q3 | $8.03K | Buy |
138
+67
| +94% | +$3.9K | 0.01% | 179 |
|
2023
Q2 | $4.54K | Sell |
71
-299
| -81% | -$19.1K | ﹤0.01% | 227 |
|
2023
Q1 | $25.7K | Sell |
370
-34
| -8% | -$2.36K | 0.03% | 139 |
|
2022
Q4 | $29.1K | Buy |
404
+22
| +6% | +$1.58K | 0.03% | 128 |
|
2022
Q3 | $27K | Sell |
382
-21
| -5% | -$1.48K | 0.03% | 125 |
|
2022
Q2 | $31K | Buy |
+403
| New | +$31K | 0.03% | 123 |
|